Documentazione scientifica

• AISF – Il trapianto di fegato – Raccomandazioni dell’Associazione Italiana per lo studio del Fegato. Commissione del febbraio 2008

• Guida al Trapianto di Fegato a cura di “Amici del trapianto di fegato Onlus”

• LinksNadalin S, Bockhorn M, Malagó M, Valentin-Gamazo C, Frilling A, Broelsch CE., Living donor liver transplantation. HPB (Oxford). 2006;8(1):10-21.

• Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008 Mar 8;371(9615):838-51. Review.
 
• LinksLee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology. 2008 Apr;47(4):1401-15. 

• Soejima Y, Taketomi A, Ikegami T, Yoshizumi T, Uchiyama H, Yamashita Y, Meguro M, Harada N, Shimada M, Maehara Y., Living donor liver transplantation using dual grafts from two donors: a feasible option to overcome small-for-size graft problems? Am J Transplant. 2008 Apr;8(4):887-92. Epub 2008 Feb 19.

• Ołdakowska-Jedynak U, Paczek L, Foroncewicz B, Mucha K, Nyckowski P, Zieniewicz K, Ziarkiewicz-Wróblewska B, Ziółkowski J, Pilecki T, Patkowski W, Górnicka B, Paczkowska A, Krawczyk M. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin. Ann Transplant. 2007;12(3):28-32.

• Wigmore SJ, Forsythe JJ., Living-related liver transplantation from the view of the donor: a 1-year follow-up survey. Transplantation 2002; 73: 1799.

• Gomez-Camarero J, Salcedo M, Rincon D, Lo Iacono O, Ripoll C, Hernando A, Sanz C, Clemente G, Bañares R. Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms. Transplantation. 2007 Sep 27;84(6):786-91

• Vincenti F. Costimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol. 2008 Feb;121(2):299-306